《Table 1Basal characteristics of patients who underwent ABO-I LDLT.》
![《Table 1Basal characteristics of patients who underwent ABO-I LDLT.》](http://bookimg.mtoou.info/tubiao/gif/GJGD201802008_32400.gif)
本系列图表出处文件名:随高清版一同展现
《A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation》
Values are presented as number(%),mean±SD or median(interquartile range).ABO-I:ABO-incompatible;BMI:body mass index;HBV:hepatitis B virus;HCC:hepatocellular carcinoma;HCV:hepatitis C virus;INR:international normalized ratio;LDLT:living donor liver tr
B cell subpopulations were not different in the two groups at the time of initial point(P=0.657)and ABO-I LDLT(P=0.079).Plasmapheresis was performed a median of 2 times(1–2.3)before surgery in the RP group(Table 1).
图表编号 | XD0020450900 严禁用于非法目的 |
---|---|
绘制时间 | 2018.04.01 |
作者 | Eung Chang Lee、Seong Hoon Kim、Jae Ryong Shim、Sang-Jae Park |
绘制单位 | Center for Liver Cancer, National Cancer Center、Center for Liver Cancer, National Cancer Center、Center for Liver Cancer, National Cancer Center、Center for Liver Cancer, National Cancer Center |
更多格式 | 高清、无水印(增值服务) |